Delete This Copy of A New Platform for Platelet Transfusion Safety
Improved Safety Increased Availability Lower Cost
An AcrodoseSM Platelet is a new generation platelet product that represents these key qualities. This innovative product is leukoreduced, pooled, ABO matched, and bacteria tested. It is designed to improve safety, increase availability, and provide blood centers with opportunities for growth. Clinically equivalent to a single donor platelet (in terms of platelet count and quality), an Acrodose platelet enables blood centers to tap into the abundant but often discarded resource of whole-blood platelets. An Acrodose Platelet offers significant cost advantages to the blood center as well as the hospital.
Using a platform of complementary products, blood collection facilities can produce a therapeutic dose of whole blood-derived platelets that are leukoreduced, ABO matched, pooled and bacteria tested with culture-based detection methods – in other words, an Acrodose Platelet.
- Breakthrough Technology from Pall Increases Platelet Availability and Safety
- Improved Blood Safety Measures from Pall Can Increase Platelet Availability
- Study on Prion Removal from Blood Published in Transfusion
Collecting and Processing
|Leukotrap® RC PL and Leukotrap PL Systems
Provide a unique combination of technologies to enhance transfusion safety and operating efficiency. The only inline filtration systems capable of producing leukocyte reduced whole-blood platelets and plasma. Providing efficient filtration for platelet-rich plasma, the ATS LPL filter allows for semiautomated processing.
Pooling and Storing
|Acrodose™ PL System
Offers blood centers a real alternative to optimize the availability, safety and cost of transfusion platelets. This system enables blood centers to provide a therapeutic dose of whole-blood-derived platelets that are leukoreduced, bacteria tested, ABO matched and standardized to meet hospital needs.
Bacteria Detection and Data Management
Pall eBDS and Pall Data*
*Pall Data with Workflow module is subject to FDA clearance and is available for beta testing in the USA.